Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free SLDB Stock Alerts

Solid Biosciences (SLDB) Short Interest Ratio & Short Volume

Solid Biosciences logo
$8.32 -0.17 (-1.94%)
As of 11:02 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Solid Biosciences Short Interest Overview

As of July 15, 2026, Solid Biosciences (SLDB) had a short interest of 17.67 million shares sold short, representing 18.44% of the public float. This marks a -3.29% decrease in short interest since the prior report. The short interest ratio (days to cover) is 11.2, meaning it would take 11.2 days of the average trading volume of 1.44 million shares to cover all short positions.

Current Short Interest
17,667,300 shares
Previous Short Interest
18,268,655 shares
Change Vs. Previous Month
-3.29%
Dollar Volume Sold Short
$169.96 million
Short Interest Ratio
11.2 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
98,450,000 shares
Short Percent of Float
18.44%
Today's Trading Volume
160,284 shares
Average Trading Volume
1,441,412 shares
Today's Volume Vs. Average
11%
Short Selling Solid Biosciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Solid Biosciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

SLDB Short Interest Over Time

SLDB Days to Cover Over Time

SLDB Percentage of Float Shorted Over Time

Solid Biosciences Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202617,667,300 shares $169.96 million -3.3%18.4%11.18 $9.62
6/30/202618,268,655 shares $182.50 million +57.3%19.1%4.57 $9.99
6/15/202611,612,697 shares $85.47 million +20.9%12.1%8.85 $7.36
5/29/20269,601,922 shares $70.48 million +5.5%10.0%9.38 $7.34
5/15/20269,104,371 shares $63.00 million +3.3%9.4%6.83 $6.92
4/30/20268,809,823 shares $63.96 million -6.7%10.4%11.08 $7.26
4/15/20269,442,052 shares $78.56 million -6.0%9.9%9.38 $8.32
3/31/202610,049,470 shares $72.36 million +3.0%10.5%7.98 $7.20
3/13/20269,752,511 shares $71.29 million +2.2%14.5%4.34 $7.31
2/27/20269,541,799 shares $59.25 million +1.2%14.2%9.14 $6.21
2/13/20269,425,420 shares $58.34 million +8.8%9.8%7 $6.19
1/30/20268,660,064 shares $55.94 million +0.7%12.9%9.48 $6.46
1/15/20268,602,169 shares $48.69 million -14.2%12.8%7.5 $5.66
12/31/202510,029,089 shares $56.56 million +0.9%14.9%10.71 $5.64
12/15/20259,943,886 shares $56.78 million -5.7%14.8%10.86 $5.71
11/28/202510,541,992 shares $57.19 million +10.4%15.7%11.19 $5.43
11/14/20259,552,193 shares $40.50 million +7.1%14.2%6.07 $4.24
10/31/20258,921,662 shares $48.09 million -6.8%13.3%10.71 $5.39
10/15/20259,570,000 shares $60.48 million -6.0%16.4%8.9 $6.32
9/30/202510,180,000 shares $62.81 million +2.4%17.5%8.4 $6.17
9/15/20259,940,000 shares $54.57 million +0.9%17.0%7.7 $5.49
8/31/20259,850,000 shares $53.98 million +0.7%16.9%7.2 $5.48
8/15/20259,780,000 shares $59.76 million -3.3%16.8%6.7 $6.11
7/31/202510,110,000 shares $69.15 million -1.2%17.9%6 $6.84
7/15/202510,230,000 shares $55.14 million +0.9%18.2%5.8 $5.39
6/30/202510,140,000 shares $49.38 million +25.5%18.0%5.9 $4.87
6/15/20258,080,000 shares $36.44 million -3.2%14.3%5.1 $4.51
5/31/20258,350,000 shares $26.72 million -7.7%14.8%5.4 $3.20
5/15/20259,050,000 shares $23.44 million +27.6%16.0%6.1 $2.59
4/30/20257,090,000 shares $23.47 million -12.0%11.0%2.6 $3.31
4/15/20258,060,000 shares $21.76 million -6.5%12.5%3.2 $2.70
3/31/20258,620,000 shares $31.89 million +10.0%12.9%3.6 $3.70
3/15/20257,840,000 shares $39.91 million +7.1%11.5%3.5 $5.09
2/28/20257,320,000 shares $40.92 million +148.1%12.3%3.4 $5.59
2/15/20252,950,000 shares $11.89 million +11.3%5.0%1.5 $4.03
1/31/20252,650,000 shares $8.43 million +13.7%8.1%5.2 $3.18
1/15/20252,330,000 shares $7.32 million +13.1%7.1%5.7 $3.14
12/31/20242,060,000 shares $8.24 million +17.1%6.3%5.3 $4.00
12/15/20241,760,000 shares $8.64 million +13.6%5.4%5.6 $4.91
11/30/20241,550,000 shares $8.84 million +2.0%4.8%5.3 $5.70
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
11/15/20241,520,000 shares $7.37 million +2.7%4.7%5.3 $4.85
10/31/20241,480,000 shares $8.17 million -16.4%4.4%5.5 $5.52
10/15/20241,770,000 shares $11.74 million +2.3%5.5%6.6 $6.63
9/30/20241,730,000 shares $12.06 million +4.2%5.3%6 $6.97
9/15/20241,660,000 shares $13.16 million -1.8%5.1%3.9 $7.93
8/31/20241,690,000 shares $15.09 million -2.3%5.2%3.6 $8.93
8/15/20241,730,000 shares $15.45 million +8.1%5.3%3.6 $8.93
7/31/20241,600,000 shares $14.27 million -3.6%5.0%3.6 $8.92
7/15/20241,660,000 shares $14.21 million -45.6%5.2%3.7 $8.56
6/30/20243,050,000 shares $17.29 million +237.4%9.6%7.8 $5.67
6/15/2024904,100 shares $7.14 million +7.6%2.8%3.1 $7.90
5/31/2024840,200 shares $6.94 million -9.6%2.7%3.4 $8.26
5/15/2024929,200 shares $9.00 million +1.7%3.0%3.8 $9.69
4/30/2024913,600 shares $8.10 million -13.0%3.0%3.6 $8.87
4/15/20241,050,000 shares $10.50 million +14.0%3.5%4 $10.00
3/31/2024920,900 shares $12.27 million +49.8%3.1%2.5 $13.32
3/15/2024614,900 shares $8.04 million -3.0%2.0%1.8 $13.08
2/29/2024633,600 shares $5.95 million +4.3%2.1%1.3 $9.39
2/15/2024607,300 shares $5.97 million +41.8%2.0%1.3 $9.83
1/31/2024428,300 shares $2.95 million +11.5%1.8%0.6 $6.89
1/15/2024384,000 shares $2.96 million +55.0%2.8%0.6 $7.71
12/31/2023247,800 shares $1.52 million +21.8%1.5%0.4 $6.14
12/15/2023203,400 shares $1.06 million -6.4%1.2%0.4 $5.19
11/30/2023217,200 shares $612.50 thousand +508.4%1.3%0.5 $2.82
11/15/202335,700 shares $97.28 thousand -5.8%0.2%0.1 $2.73
10/31/202337,900 shares $84.52 thousand +76.3%0.2%1.4 $2.23
10/15/202321,500 shares $46.44 thousand -27.4%0.1%0.9 $2.16
9/30/202329,600 shares $74.59 thousand -0.3%0.2%2 $2.52
9/15/202329,700 shares $92.66 thousand -1.3%0.2%2.3 $3.12
8/31/202330,100 shares $108.66 thousand -30.0%0.2%1.4 $3.61
8/15/202343,000 shares $161.47 thousand +24.6%0.3%2.1 $3.76
7/31/202334,500 shares $148.70 thousand -20.0%0.2%1.6 $4.31
7/15/202343,100 shares $211.63 thousand -1.4%0.3%1.7 $4.91
6/30/202343,700 shares $228.99 thousand +7.1%0.3%1.6 $5.24
6/15/202340,800 shares $255.41 thousand +60.0%0.3%1.3 $6.26
5/31/202325,500 shares $157.59 thousand -37.4%0.2%0.8 $6.18
5/15/202340,700 shares $254.38 thousand +5.4%0.3%1.2 $6.25
4/30/202338,600 shares $188.37 thousand -14.2%0.3%1.1 $4.88
4/15/202345,000 shares $228.15 thousand +24.7%0.3%1.2 $5.07
3/31/202336,100 shares $171.11 thousand +71.9%0.2%1 $4.74
3/15/202321,000 shares $100.80 thousand +62.8%0.1%0.6 $4.80
2/28/202312,900 shares $72.50 thousand -6.5%0.1%0.5 $5.62
2/15/202313,800 shares $92.60 thousand -85.2%0.1%0.5 $6.71
1/31/202393,200 shares $706.46 thousand +162.5%1.0%3.3 $7.58
1/15/202335,500 shares $239.63 thousand -36.2%0.4%1.1 $6.75
12/30/202255,600 shares $299.13 thousand -27.8%0.6%1.8 $5.38
12/15/202277,000 shares $527.45 thousand -21.5%2.1%2.3 $6.85
11/30/202298,100 shares $657.27 thousand -11.1%1.6%3.1 $6.70
11/15/2022110,400 shares $734.16 thousand +69.1%1.8%3.7 $6.65
10/31/202265,300 shares $418.57 thousand -91.3%1.0%2 $6.41
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
10/15/2022749,700 shares $342.09 thousand +10.7%0.8%1.9 $0.46
9/30/2022677,300 shares $316.03 thousand -2.6%0.8%1.7 $0.47
9/15/2022695,500 shares $443.31 thousand +59.8%0.8%1.3 $0.64
8/31/2022435,200 shares $278.53 thousand -17.2%0.5%0.7 $0.64
8/15/2022525,600 shares $435.62 thousand +14.7%0.6%0.8 $0.83
7/31/2022458,400 shares $309.42 thousand -27.0%0.5%0.7 $0.68
7/15/2022628,100 shares $425.22 thousand -89.8%0.7%0.8 $0.68
6/30/20226,180,000 shares $3.80 million -25.5%7.3%7.9 $0.62
6/15/20228,290,000 shares $4.93 million No Change9.7%11 $0.59
5/31/20228,290,000 shares $4.73 million -0.5%9.7%10.2 $0.57
5/15/20228,330,000 shares $4.20 million +1.7%9.8%10.7 $0.50
4/30/20228,190,000 shares $4.59 million +15.2%9.4%9.9 $0.56
4/15/20227,110,000 shares $7.47 million -6.1%8.4%7.8 $1.05
3/31/20227,570,000 shares $9.08 million -1.3%8.9%6.9 $1.20
3/15/20227,670,000 shares $7.56 million +14.0%9.0%6.9 $0.99
2/28/20226,730,000 shares $5.48 million +1.2%7.9%5.7 $0.82
2/15/20226,650,000 shares $7.18 million -6.7%7.9%4.7 $1.08
1/31/20227,130,000 shares $8.70 million +4.9%8.5%4.5 $1.22
1/15/20226,800,000 shares $9.52 million +8.8%10.5%4.3 $1.40
12/31/20216,250,000 shares $10.94 million +1.3%9.7%4.3 $1.75
12/15/20216,170,000 shares $11.41 million No Change9.6%4.1 $1.85
11/30/20216,170,000 shares $10.80 million -6.5%9.6%3.5 $1.75
11/15/20216,600,000 shares $14.32 million -4.4%10.2%4.9 $2.17
10/29/20216,900,000 shares $14.01 million -2.4%10.7%6 $2.03
10/15/20217,070,000 shares $15.91 million +1.1%10.9%7.1 $2.25
9/30/20216,990,000 shares $16.71 million +9.6%10.8%7.5 $2.39
9/15/20216,380,000 shares $16.78 million -2.6%9.9%6.8 $2.63
8/31/20216,550,000 shares $17.75 million -5.1%10.1%10.7 $2.71
8/13/20216,900,000 shares $18.35 million +0.7%10.7%9 $2.66

SLDB Short Interest - Frequently Asked Questions

Short interest is the volume of Solid Biosciences shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 17,667,300 shares of SLDB short. 18.44% of Solid Biosciences' shares are currently sold short. Learn More on Solid Biosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLDB shares currently have a short interest ratio of 11.2. Learn More on Solid Biosciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.44% of Solid Biosciences' floating shares are currently sold short.

Solid Biosciences saw a drop in short interest during the month of July. As of July 15th, there was short interest totaling 17,667,300 shares, a drop of 3.3% from the previous total of 18,268,655 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

18.44% of Solid Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Solid Biosciences: IDEAYA Biosciences, Inc. (11.43%), MBX Biosciences, Inc. (17.61%), Disc Medicine, Inc. (19.85%), Regencell Bioscience Holdings Limited (0.19%), Beam Therapeutics Inc. (23.46%), Atai Beckley N.V. (12.80%), Immunome, Inc. (16.40%), Trevi Therapeutics, Inc. (10.53%), uniQure N.V. (17.24%), Tarsus Pharmaceuticals, Inc. (14.88%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling SLDB is an investing strategy that aims to generate trading profit from Solid Biosciences as its price is falling. SLDB shares are trading up $0.45 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Solid Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLDB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLDB, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like SLDB:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:SLDB) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel